WHO puts ‘temporary pause’ on hydroxychloroquine trial for coronavirus patients

A trial of hydroxychloroquine for COVID-19 treatment has been suspended after researchers found patients receiving the drug were at higher risk of heart problems and death.

Diary of a pharmacist in lockdown

Accredited pharmacist Kay Morey MPS has been in the thick of the COVID-19 crisis. She shares what life has been like during the past 7 months.

Why pharmacist accreditation is important

With demand for pharmacists in aged care set to rise, and the removal of the re-accreditation fee, there has never been a better time to broaden your scope of practice through accreditation.

Determinants of health and reducing health inequity

Health can be defined in many ways and is influenced by context, culture and an individual's belief systems.

How the COVID-19 Home Medicines Service works

Pharmacies will receive a $5 service fee for every eligible home delivery made through the new Home Medicines Service scheme, designed to protect the most vulnerable Australians from exposure to COVID-19.

Chlorpromazine: from antihistamine to antipsychotic

While chlorpromazine’s use on people with schizophrenia has been overtaken by atypical antipsychotics, it is still used widely.